Literature DB >> 17764767

Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.

Jaroslav Meluzín1, Stanislav Janousek, Jirí Mayer, Ladislav Groch, Ivan Hornácek, Ota Hlinomaz, Petr Kala, Roman Panovský, Jirí Prásek, Milan Kamínek, Jaroslav Stanícek, Martin Klabusay, Zdenek Korístek, Milan Navrátil, Ladislav Dusek, Jaroslava Vinklárková.   

Abstract

BACKGROUND: There are only few data on long-term effectiveness of the stem cell therapy. AIM: We studied the time course of global and regional left ventricular function in patients with acute myocardial infarction within 1 year after the autologous mononuclear bone marrow cell transplantation.
METHODS: Sixty patients with a first acute myocardial infarction, who had been randomized into 3 groups, completed a 12-month protocol. Two groups were intracoronarily given bone marrow cells in either higher (10(8) cells, HD group, n=20) or lower (10(7) cells, LD group, n=20) doses. Twenty patients without cell transplantation served as a control (C) group. Doppler tissue imaging and the gated technetium-99m sestamibi single photon emission computed tomography were performed before cell transplantation and at 3, 6, and 12 months later.
RESULTS: The baseline peak systolic velocities of longitudinal contraction of the infarcted wall (S(infarct)) of 5.2 cm/s, 4.6 cm/s, and 4.4 cm/s in C, LD, and HD groups increased by 0.0 cm/s, 0.3 cm/s (p=NS vs. C group), and by 0.7 cm/s (p<0.05 vs. C group), respectively, at 3 months. At 12 months, however, the corresponding changes from baseline values of 0.1 cm/s, 0.2 cm/s, and 0.6 cm/s did not differ significantly (all p=NS). In contrast, the post-transplant improvements in the left ventricular ejection fraction by 6%, 7%, and 7% at months 3, 6, and 12, respectively, were preserved in HD group patients during the whole 12-month follow-up and remained significantly better as compared to controls.
CONCLUSIONS: In our study, the autologous mononuclear bone marrow cell transplantation provided sustained improvement in global left ventricular systolic function in patients with acute myocardial infarction. However, when evaluating regional systolic function of the infarcted wall, the short-term benefit was partially lost during the 12-month follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 17764767     DOI: 10.1016/j.ijcard.2007.04.098

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  39 in total

Review 1.  Cell delivery routes for stem cell therapy to the heart: current and future approaches.

Authors:  Niall G Campbell; Ken Suzuki
Journal:  J Cardiovasc Transl Res       Date:  2012-05-31       Impact factor: 4.132

2.  The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.

Authors:  Kamel Sadat; Sameer Ather; Wael Aljaroudi; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2013-12-31       Impact factor: 5.952

Review 3.  Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!

Authors:  C V Borlongan
Journal:  Leukemia       Date:  2011-07-05       Impact factor: 11.528

4.  Clinical trials of cardiac repair with adult bone marrow- derived cells.

Authors:  Vinodh Jeevanantham; Mohammad R Afzal; Ewa K Zuba-Surma; Buddhadeb Dawn
Journal:  Methods Mol Biol       Date:  2013

Review 5.  Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis.

Authors:  Vinodh Jeevanantham; Matthew Butler; Andre Saad; Ahmed Abdel-Latif; Ewa K Zuba-Surma; Buddhadeb Dawn
Journal:  Circulation       Date:  2012-06-22       Impact factor: 29.690

Review 6.  Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review.

Authors:  Paulino A Alvarez; Ernst R Schwarz; Rajesh Ramineni; Phil Myatt; Clay Barbin; Carlos Boissonnet; Anita Phan; Aldo Maggioni; Alejandro Barbagelata
Journal:  Clin Res Cardiol       Date:  2012-09-28       Impact factor: 5.460

7.  In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.

Authors:  Ahmad Y Sheikh; Bruno C Huber; Kazim H Narsinh; Joshua M Spin; Koen van der Bogt; Patricia E de Almeida; Katherine J Ransohoff; Daniel L Kraft; Giovanni Fajardo; Diego Ardigo; Julia Ransohoff; Daniel Bernstein; Michael P Fischbein; Robert C Robbins; Joseph C Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

Review 8.  Cardiac repair with adult bone marrow-derived cells: the clinical evidence.

Authors:  Buddhadeb Dawn; Ahmed Abdel-Latif; Santosh K Sanganalmath; Michael P Flaherty; Ewa K Zuba-Surma
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 9.  Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue.

Authors:  Maritza Mayorga; Amanda Finan; Marc Penn
Journal:  Stem Cell Rev Rep       Date:  2009-01-30       Impact factor: 5.739

10.  Endothelial progenitor cells: what use for the cardiologist?

Authors:  Aurangzeb Siddique; Eduard Shantsila; Gregory Yh Lip; Chetan Varma
Journal:  J Angiogenes Res       Date:  2010-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.